FRANKFURT (Reuters) -Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion (NASDAQ:ALXN) Pharmaceuticals for $39 billion in its largest ever deal, diversifying away from its fast-growing cancer business in a…
Trending News
September 29, 2025
September 9, 2025
September 5, 2025
September 2, 2025
September 2, 2025